MC225 compound: Clinical Trials

2 trials of MC225 compound, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Unknown 1
Phase 21Unknown 1

Follow MC225 compound: new trials by email Literature Review of MC225 compound trials Research Report on MC225 compound

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[18F]MC225 PET to Evaluate Gender Differences in BBB P-gp Function
[18F]MC225 - Gender
Not applicableUnknownUniversity Medical Center Groningen102023-01-012022-11-16
[18F]MC225-PET in Neurodegenerative Disease
[18F]MC225 - Neurodegenerative Diseases, Alzheimer Disease
Phase 1 / Phase 2UnknownUniversity Medical Center Groningen302022-02-012023-05-10

Conditions studied

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Coitus (1)  ·  Neurodegenerative Diseases (1)  ·  Parkinson Disease (1)

Sponsors

University Medical Center Groningen (2)

Countries

Netherlands (1)

Top investigators

Gert Luurtsema, Phd (1)

Results publications

PMID 40538986